No association of rs1065852 and rs3892097 polymorphisms gene CYP2D6 with treatment resistant schizophrenia
According to modern data, about a third of patients suffering from schizophrenia are considered treatment resistant. The metabolism of about 20% of medicines and mainly psychotropic drugs is caused by the isoenzyme CYP2D6. This article presents the data of the CYP2D6 gene study as biomarkers for the...
Saved in:
| Main Authors: | D. N. Sosin, M. V. Ivanov, L. M. Muslimova, D. V. Ivashchenko, D. A. Sychev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation
2019-12-01
|
| Series: | Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева |
| Subjects: | |
| Online Access: | https://www.bekhterevreview.com/jour/article/view/333 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacogenetics of schizophrenia in real clinical practice: a clinical case
by: R. F. Nasyrova, et al.
Published: (2018-12-01) -
New approaches to pharmacogenetics of drug-induced hyperprolactinemia in patients with schizophrenia
by: S. A. Ivanova
Published: (2019-12-01) -
Polymorphic variant of <i>NQO1</i> rs1800566 and antipsychotic-induced metabolic disorders in patients with schizophrenia
by: V. V. Tiguntsev, et al.
Published: (2025-07-01) -
The prevalence of CYP2D6*10 (100C>T, rs1065852) gene polymorphism in Russian patients with epilepsy (North-Western and Siberian Districts)
by: N. A. Sivakova, et al.
Published: (2019-12-01) -
CYP2D6 polymorphism rs1065852 significantly increases the risk of type 2 diabetes
by: Huiyi Wei, et al.
Published: (2025-12-01)